Skip to content

COMED

Active Private limited companyfounded 2023active for 2 yearsBoeleberg 2, 3730 Bilzen-HoeseltKBO/BCE: BE 1002.761.947

Lifetime

2 annual accounts with figures on one time axis
peak of €791,996 in 2025
€791,996▲ 27.7%
lowest -€711 in 2024
€17,961▲ €18,673
peak of €20,250 in 2025
€20,250▲ 785%
€1.3m▲ 5.8%
peak of 8.4 FTE in 2025
8.4 FTE▲ 9.1%
Board2 names since 2023
2 directors and 1 other
Documentsfilings and deeds
27-07-20264 days before the deadline
2025abbreviated format
Gross margin from €620,414 to €791,996Profit of €17,961, after a lossStaff from 7.7 FTE to 8.4 FTERegistered office moved from Hoeselt to Bilzen-Hoeselt 07-04Equity from €2,289 to €20,250Cash from €179,429 to €112,309

Key points

from the 2025 annual accounts

Turnover

≈ €1.9m estimated

The abbreviated format states no turnover.

Debts

€1.3m 98% of the balance sheet
Financial debts 24%Suppliers 13%Taxes and wages 4%Other 59%

Of this, €1.0m falls due within a year.

Staff

7 employees on 31-12-2025
1572024782025

In 2025, 7 employees joined and 8 left.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 2,136 companies had the same profile as COMED has now. Each dot stands for 6 companies, two years later.

92.0%
were still trading
2.3%
stopped another way
5.2%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency under 10%
  • a profit under 5% of the balance sheet

Another 0.4% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 2,136 companies, not a prediction for COMED. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 28-11-2023
Director, since 28-11-2023
  • 50 sharesdeed of 30-11-2023
  • 50 sharesdeed of 30-11-2023
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:1002761947
Registered office moved from Hoeselt to Bilzen-Hoeselt The registered office moved from O.-L.-Vrouwstraat 2, 3730 Hoeselt to Boeleberg 2, 3730 Bilzen-Hoeselt · General meeting of 01-03-2025 · Gazette deed
Incorporation Founded by and · 100 shares · (director) and (director) appointed · published on 30-11-2023 · Gazette deed
2 establishments registered Bilzen-Hoeselt
All 7 events

Comparable companies

same main activity, similar in size and age
Company
COMED Bilzen-Hoeselt €1.3m €0.8m 1.5% 8.4
Flindr Labs Ghent €0.3m €0.3m -148.7% 4.2
272BIO Ghent €0.7m €0.1m -31.8% 5.2
OLYS Pharma La Hulpe €1.0m €0.2m 56.0% -
Ziphius Ghent €9.5m €2.4m 62.1% 41.2
INTIBIO Bree €0.4m €0.3m 35.8% -
AnimAb Ghent €3.5m €0.03m 79.6% 5.6

These companies have the same main activity as COMED: manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21201). They are comparable in size and age: total assets between €263,000 and €9.5m, founded between 2019 and 2024.

Official details

Source: KBO
Status
Active since 28-11-2023Normal situation
Activity
Manufacture of basic pharmaceutical products and pharmaceutical preparationsNACE 21201and 4 others
Joint committees
116Chemical industry
201Independent retail
207White-collar workers in the chemical industry · annual accounts 2025
Establishment units
2.352.731.2383730 Bilzen-Hoeselt, since 28-11-2023
2.352.731.3373730 Bilzen-Hoeselt, registered on 28-11-2023
Financial year end
31 December
Peppol
Reachable since 15-07-2026
Company details

Annual accounts 2025

€1.3m▲ 7.2%
Employeeson 31-12-2025
7▼ 12.5%
Filing
Filed on 27-07-2026, 4 days before the end of the filing period
Financials

Insights on COMED

The 2025 annual accounts show equity of €20,250 and a net result of €17,961. Its solvency ranks better than 21% of 84 sector peers (NACE 21) in financial year 2025.

The company has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about COMED

What is the company number of COMED?
The company number of COMED is 1002.761.947. The VAT number is the same number with BE in front: BE 1002.761.947.
Where is COMED based?
The registered office is at Boeleberg 2, 3730 Bilzen-Hoeselt.Company details
What does COMED do?
According to the KBO register, the main activity is manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21201).
What is the legal form of COMED?
COMED is a private limited company (BV).
When was COMED founded?
COMED was founded on 28-11-2023.
Is COMED still active?
Yes, COMED is an active enterprise in the KBO register.
How many employees does COMED have?
COMED had an average of 8.4 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does COMED fall under?
In its 2025 annual accounts, COMED states joint committees 116 (Chemical industry), 201 (Independent retail) and 207 (White-collar workers in the chemical industry).
What is the turnover of COMED?
The turnover in financial year 2025 is ≈ €1.9m. This figure is estimated from the gross margin of €791,996 and 2,136 comparable companies of the same size. It probably lies between €1.1m and €3.3m. It is a rough estimate.
Is COMED profitable?
In financial year 2025, COMED made a profit of €17,961.
Where can I find the annual accounts of COMED?
COMED filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of COMED due?
COMED must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.